Vendor, Honolulu, HI
Hawaii Biotech, Inc.
UEI ECJKEEFL4L51, CAGE 0EAY9
1 award and -$1,636 obligated between August 6, 2026 and August 6, 2026, 100% under full and open competition, against 24.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | -$1,636 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N93018C00023Definitive Contract, August 6, 2026, Full and Open Competition, 24 offers | National Institutes of Health NiaidNational Institutes of Health | To Administrate De-Obligate Unexpended and Expiring Fiscal Year 2021 Funding in Accordance with 31 U.S.C. Section 1552 (A), in Preparation fNAICS 541714, PSC AN12 | -$1,636 |
- Places of performance
- Hawaii
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 1 across 1 awards